Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL-Reference-Cited by-同舟云学术

Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mL

Published:2012-11-15 Issue:11 Volume:7 Page:e50065
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Henrich Timothy J.,Wood Brian R.,Kuritzkes Daniel R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference16 articles.

1. Panel on Antiretroviral Guidelines for Adults and Adolescents (2011) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services.

2. Reliability at the lower limits of HIV-1 RNA quantification in clinical samples: a comparison of RT-PCR versus bDNA assays;RJ Lubelchek;PLoS One,2009

3. Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay;E Smit;J Acquir Immune Defic Syndr,2009

4. Results of the Abbott RealTime HIV-1 Assay for Specimens Yielding “Target Not Detected” Results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test;NE Babady;J Clin Microbiol,2010

5. Potential Influence of More-Sensitive HIV-1 Load Detection by the new Roche Cobas AmpliPrep/Cobas TaqMan Version 2.0 Assay on Clinical Management of HIV-Positive Pregnant Women;MGJ de Boer;J Clin Microbiol,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Rebound After Antiviral Treatment: A Mathematical Modeling Study of the Role of Antiviral Mechanism of Action;Interdisciplinary Sciences: Computational Life Sciences;2024-07-21

2. Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy;HIV Medicine;2024-06-04

3. Factors associated with viral suppression and rebound in adult HIV patients on antiretroviral therapy;Journal of Public Health and Epidemiology;2023-12-31

4. Predictors of Detectable Viremia, Outcomes, and Implications for Management of People Living With HIV Who Are Receiving Antiretroviral Therapy in Southern Nigeria;Open Forum Infectious Diseases;2023-11-09

5. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12